Latest Strategic Leadership News

WiseTech Global reported a robust FY25 with 14% revenue growth and a 17% rise in net profit, underpinned by a transformative $2.1 billion acquisition of e2open and strategic leadership changes.

Tabcorp Holdings Limited has reported a significant financial turnaround for FY25, driven by the new Victorian Wagering and Betting Licence and strategic operational improvements. The company posted $2.6 billion in revenue and a net profit after tax of $36.6 million, reversing last year's substantial loss.

Race Oncology Limited reported a significantly reduced loss for FY2025, driven by key clinical trial progress and strategic leadership changes. The company advances its RC220 program with promising Phase 1 dosing milestones and strengthens its governance to support future growth.

Fluence Corporation has announced Ben Fash as its new CEO and Managing Director, succeeding Tom Pokorsky who will retire after a distinguished career. The transition marks a strategic leadership shift aimed at driving future growth.

Australian Clinical Labs reported a 6.4% revenue increase and an 8.7% rise in underlying EBIT for FY25, maintaining disciplined growth and operational efficiency in a complex healthcare environment.

LaserBond announces a strategic leadership transition with Rob Freeman appointed CEO, succeeding long-time leader Wayne Hooper who remains as Executive Director in an advisory capacity.

Petratherm Limited advances its Rosewood Titanium Project with the appointment of a seasoned project development head and an increased stake in a key joint venture, alongside promising metallurgical test results.

Life360 reported record Q2 2025 results with robust subscription growth and raised full-year guidance, alongside a strategic leadership transition appointing Lauren Antonoff as CEO.

Orbital Corporation has denied any undisclosed information behind its recent share price jump, attributing market interest to strategic leadership appointments aimed at expanding its UAV propulsion business.

Finexia Financial Group announces a strategic leadership reshuffle with the return of Neil Sheather as CEO and Managing Director, the appointment of Robert Spano as Executive Chairman, and a new CEO for its childcare subsidiary, Shared Beginnings.

Neuren Pharmaceuticals reports a 16% rise in Q2 2025 royalties driven by Acadia’s DAYBUE sales growth and expanding patient base in the US. Full-year sales guidance remains strong with European market entry on the horizon.

SRJ Technologies reports a robust 81% increase in quarterly cash receipts, driven by strategic leadership changes and a focused expansion into the Middle East and other high-growth markets.